Cancer care innovator. Educator. Hockey fanatic.

Howard Lim, a Clinical Associate Professor with the Faculty of Medicine’s Department of Medicine, is a medical oncologist at the B.C. Cancer Agency specializing in gastrointestinal cancer.

Through his work at the BC Cancer Agency, and as co-investigator of the clinical research initiative known as Personalized OncoGenomics (or POG), Dr. Lim is helping to revolutionize our understanding of cancer diagnosis, while seeking to pioneer a new — and personalized — approach to treating cancer. Dr. Lim is also passionate about training the next generation of physicians, serving as the director of UBC’s Medical Oncology Residency Program.

Over the past 150 years, what do you think is the most important Canadian discovery, contribution or achievement in health research or education?

Canadians have had a long-standing history of contributing to health science research. I think the most important contribution and achievement we have made is to provide universal health care for all of our citizens. This basic right provides the pillar for all Canadians to continue to advance our society through innovation and education. By providing a foundation of care, Canadians can focus on contributing, as well as leading world-class research.

Looking towards the future, what new health discovery, treatment or innovation will come from Canada?

The genomic revolution has been a long-standing strength at UBC, with the Nobel Prize being awarded to Dr. Michael Smith. We continue to lead the world with the Genome Science Centre and genomic information will transform the health care sector. The use of this information can empower people to take control of their health, while also providing more efficient care through personalized medicine.

What is your favourite Canadian pastime?

Hockey! Especially World Junior or Olympic hockey. And nothing beats playing some pick up hockey with good friends!